Some studies have examined CYP19A1 gene expression in breast cancer using quantitative reverse transcription polymerase chain reaction (RT-PCR), which is considered a standard method for the quantitative measurement of gene expression; however, many of these studies have shown controversial results [16, 17]. The gene discussed is CYP19A1; the disease is breast carcinoma.